10 Pharma And Wellness Firms That Have Filed DRHP With Sebi For IPO

Planning

oi-Roshni Agarwal

|

Updated: Friday, October 22, 2021, 6:58 [IST]

IPO market has been enticing retail category to institutional investors such as mutual funds and as per a report for the September month mutual funds lapped up IPO stocks worth some good substantial amount. Now as the street has been witnessing some correction owing to profit booking but by and large the sentiment looks positive, there will be continue to be seen IPOs tapping the current momentum.

Within the sector the pharma sector is riding the IPO wave with not just listing gains but also is offering stupendous returns ever since listing. Now of the Rs. 65000 crore raised through the IPO route so far this year, close to 22 percent has been accounted by the healthcare and pharma space.

Now after a strong number from the space has already made its way to the D-street, few more in the pipeline that have done their initial formality by filing an IPO DRHP are given below:

1 Wellness Forever Medicare:

This is an Adar Poonawalla-backed company that has filed DRHP for Rs. 1500 crore IPO.offer. The IPO consists of a fresh issue of equity shares up to Rs 400 crore and an offer for sale up to 1.60 crore equity shares, according to DRHP. This is the second IPO by a pharmacy chain that is based out of Mumbai with presence in as many as 23 cities across Maharashtra, Goa, and Karnataka.

2. Global Health Ltd./Medanta Hospitals:

The group that operates hospital under the brand name Medanta has filed for an initial share sale. The initial public offering (IPO) consists of a fresh issue of equity shares aggregating to Rs 500 crore, and an offer for sale of up to 4.84 crore equity shares, according to the draft red herring prospectus (DRHP).

In the current regime, there are 4 hospitals operating from 4 cities and one is under construction in Patna and the other is planned for Noida.

3. Sahajanand Medical Technologies:

The heart stent making company has filed for Rs. 1500 crore IPO. The issue comprises a fresh issue of shares of around Rs 410 crores and an offer for sale component of Rs 1,089 crore. It will also provide a partial exit to the investors Morgan Stanley Private Equity Asia and Samara Capital who hold 18.44 percent and 36.59 percent, respectively, in the company.

4. Veeda Clinical Research Limited:

The clinical research entity Veeda Clinical Research Limited has filed its draft red herring prospectus (DRHP) with capital markets regulator Securities and Exchange Board of India (Sebi) for raising funds from the primary markets.

The issue will consist of an issuance of fresh equity shares worth up to Rs331.60cr and an offer for sale (OFS) of Rs500cr by promoters and existing shareholders.

5. Healthium Medtech:

The global medtech company with focus chiefly on surgical, post surgical as well as chronic care has filed for an IPO. The public issue comprises a fresh issue of Rs 390 crore and an offer for sale of 3.91 crore equity shares by selling shareholders. The funds raised from the fresh issue are proposed to be utilised for repaying debts, investments in subsidiary firms, acquisitions and other strategic initiatives and general corporate purposes.

6. MedPlus Health Service:

Hyderabad based Pharmacy retailing company has filed DRHP for Rs. 1639 crore IPO. The IPO shall include a fresh issuance of shares worth Rs 600 crore and an offer for sale (OFS) of equity up to Rs 1,038.7 crore by promoter and shareholders.
The company’s offerings range from pharmaceutical and wellness products including medicines, vitamins, medical devices and test kits, and FMCG products such as home and personal care products including toiletries, baby care products, soaps and detergents and sanitisers.

7. Infinion Biopharma IPO:

The company has filed DRHP for the sale of 45 lakh equity shares of the company.

This is a life sciences company
Infinion Biopharma is an innovation-driven life sciences company integrating biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas.

8. Emcure Pharma:

The leading pharma company is expected to float an IPO of Rs. 4500-5000 crore IPO . The initial public offering (IPO) comprises fresh issuance of equity shares worth Rs. 1,100 crore and an offer of sale (OFS) of 18,168,356 shares by promoters and existing shareholders, according to the draft red herring prospectus (DRHP).
The company produces a broad range of pharma products across therapeutic areas.

9. Supriya Lifesciences:

The Mumbai based drug making company has filed an IPO for Rs. 1200 crore IPO.
According to the prospectus, the IPO consists of a fresh issue of shares worth Rs 200 crore and an offer of sale (OFS) of shares worth up to Rs 1,000 crore held by its promoter Satish Waman Wagh. The face value of each share is Rs 2.

The company is the leading manufacturer and supplier of APIs with a focus on research and development.

10. VLCC Health care ltd.:

The wellness company has filed for raising funds via an IPO.The company in 2016 had withdrawn its IPO because of demonetization then. The initial public offering comprises a fresh issue of Rs 300 crore by the company and an offer for sale of 89,22,672 equity shares by promoter and investors.